P3 Health Partners Inc.
PIII
$0.1851
-$0.0009-0.48%
| Weiss Ratings | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.38 | |||
| Price History | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.99% | |||
| 30-Day Total Return | -6.47% | |||
| 60-Day Total Return | -19.97% | |||
| 90-Day Total Return | -57.87% | |||
| Year to Date Total Return | -25.96% | |||
| 1-Year Total Return | -83.76% | |||
| 2-Year Total Return | -83.47% | |||
| 3-Year Total Return | -97.24% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -83.97% | |||
| 52-Week Low % Change | 9.28% | |||
| Price | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.16 | |||
| 52-Week Low Price | $0.17 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 30.29M | |||
| Enterprise Value | 255.32M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.22 | |||
| Earnings Per Share Growth | -54.65% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.02 | |||
| Price/Book (Q) | 0.25 | |||
| Enterprise Value/Revenue (TTM) | 0.17 | |||
| Price | $0.19 | |||
| Enterprise Value/EBITDA (TTM) | -1.54 | |||
| Enterprise Value/EBIT | -1.01 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 164.70M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 910 3950 | |||
| Address | 2370 Corporate Circle Henderson, NV 89074 | |||
| Website | p3hp.org | |||
| Country | United States | |||
| Year Founded | 2020 | |||
| Profitability | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -17.10% | |||
| Profit Margin | -6.95% | |||
| Management Effectiveness | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.25% | |||
| Return on Equity | -- | |||
| Income Statement | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.48B | |||
| Total Revenue (TTM) | 1.48B | |||
| Revenue Per Share | $8.97 | |||
| Gross Profit (TTM) | -40.20M | |||
| EBITDA (TTM) | -166.08M | |||
| EBIT (TTM) | -252.62M | |||
| Net Income (TTM) | -102.69M | |||
| Net Income Avl. to Common (TTM) | -102.69M | |||
| Total Revenue Growth (Q YOY) | 25.58% | |||
| Earnings Growth (Q YOY) | -175.82% | |||
| EPS Diluted (TTM) | -1.22 | |||
| EPS Diluted Growth (Q YOY) | -163.20% | |||
| Balance Sheet | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 62.96M | |||
| Cash Per Share (Q) | $0.38 | |||
| Total Current Assets (Q) | 215.07M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 263.91M | |||
| Current Ratio (Q) | 0.531 | |||
| Book Value Per Share (Q) | $0.74 | |||
| Total Assets (Q) | 833.33M | |||
| Total Current Liabilities (Q) | 405.32M | |||
| Total Debt (Q) | 144.59M | |||
| Total Liabilities (Q) | 569.42M | |||
| Total Common Equity (Q) | 120.51M | |||
| Cash Flow | PIII - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 15.21M | |||
| Cash from Financing (TTM) | 64.21M | |||
| Net Change in Cash (TTM) | 10.66M | |||
| Levered Free Cash Flow (TTM) | 36.38M | |||
| Cash from Operations (TTM) | -68.77M | |||
